Announcements Trials

Browse Landscape

Phase

Status

Completed 6 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 79 Nasopharyngeal Carcinoma 51 Uterine Cervical Neoplasms 44 Lung Neoplasms 38 Esophageal Neoplasms 32 Head and Neck Neoplasms 28 Esophageal Squamous Cell Carcinoma 28 Squamous Cell Carcinoma of Head and Neck 22 Stomach Neoplasms 20 Breast Neoplasms 16 Small Cell Lung Carcinoma 15 Recurrence 12 Neoplasm Metastasis 12 Nasopharyngeal Neoplasms 12 Carcinoma, Squamous Cell 10 Ovarian Neoplasms 9 Central Nervous System Neoplasms 9 Neuroblastoma 8 Lymphoma, Large B-Cell, Diffuse 8 Pancreatic Neoplasms 7 Lymphoma 7 Hypopharyngeal Neoplasms 7 Triple Negative Breast Neoplasms 6 Oropharyngeal Neoplasms 6 Neoplasms 6 Biliary Tract Neoplasms 6 Urinary Bladder Neoplasms 5 Lymphoma, Non-Hodgkin 5 Lymphoma, Large-Cell, Immunoblastic 5 Lymphoma, Follicular 5

Interventions

dehydroftorafur 1 Taxes 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Platinum 1 Paclitaxel 1 Immune Checkpoint Inhibitors 1 Fluorouracil 1 Cisplatin 1 Chemoradiotherapy 1 Carboplatin 1 Capecitabine 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Anal Canal Carcinoma × Cisplatin × Clear all

NCT02560298 2023-06-22

InterAACT

Eastern Cooperative Oncology Group

Phase 2 Unknown

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡